|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Abad A, Massutí B, Gallego J, Yuste AL,
Manzano JL, Carrato A, Antón A, Marfa X and Diaz-Rubio E; Spanish
Cooperative Group for Gastrointestinal Tumor Therapy, : Phase I
study of the combination of oxaliplatin, irinotecan and continuous
infusion 5-fluorouracil in digestive tumors. Anticancer Drugs.
15:469–471. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Panczyk M: Pharmacogenetics research on
chemotherapy resistance in colorectal cancer over the last 20
years. World J Gastroenterol. 20:9775–9827. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shibata S: Chemistry and cancer preventing
activities of ginseng saponins and some related triterpenoid
compounds. J Korean Med Sci. 16 (Suppl):S28–S37. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kwon HY, Kim EH, Kim SW, Kim SN, Park JD
and Rhee DK: Selective toxicity of ginsenoside Rg3 on multidrug
resistant cells by membrane fluidity modulation. Arch Pharm Res.
31:171–177. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xie J, Shao J, Lu Y, Chen J, Wang J, Yu S
and Jia L: Separation of ginseng active ingredients and their roles
in cancer metastasis supplementary therapy. Curr Drug Metab.
14:616–623. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu FY, Shang WQ, Yu JJ, Sun Q, Li MQ and
Sun JS: The antitumor activity study of ginsenosides and
metabolites in lung cancer cell. Am J Transl Res. 8:1708–1718.
2016.PubMed/NCBI
|
|
8
|
Dong H, Bai LP, Wong VK, Zhou H, Wang JR,
Liu Y, Jiang ZH and Liu L: The in vitro structure-related
anti-cancer activity of ginsenosides and their derivatives.
Molecules. 16:10619–10630. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li B, Zhao J, Wang CZ, Searle J, He TC,
Yuan CS and Du W: Ginsenoside Rh2 induces apoptosis and
paraptosis-like cell death in colorectal cancer cells through
activation of p53. Cancer Lett. 301:185–192. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Choi S, Kim TW and Singh SV: Ginsenoside
Rh2-mediated G1 phase cell cycle arrest in human breast cancer
cells is caused by p15 Ink4B and p27 Kip1-dependent inhibition of
cyclin-dependent kinases. Pharm Res. 26:2280–2288. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park HM, Kim SJ, Kim JS and Kang HS:
Reactive oxygen species mediated ginsenoside Rg3- and Rh2-induced
apoptosis in hepatoma cells through mitochondrial signaling
pathways. Food Chem Toxicol. 50:2736–2741. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Favaloro B, Allocati N, Graziano V, Di
Ilio C and De Laurenzi V: Role of apoptosis in disease. Aging
(Albany NY). 4:330–349. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hengartner MO: The biochemistry of
apoptosis. Nature. 407:770–776. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Würstle ML, Laussmann MA and Rehm M: The
central role of initiator caspase-9 in apoptosis signal
transduction and the regulation of its activation and activity on
the apoptosome. Exp Cell Res. 318:1213–1220. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brown JM and Attardi LD: The role of
apoptosis in cancer development and treatment response. Nat Rev
Cancer. 5:231–237. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo XX, Guo Q, Li Y, Lee SK, Wei XN and
Jin YH: Ginsenoside Rh2 induces human hepatoma cell apoptosisvia
bax/bak triggered cytochrome C release and caspase-9/caspase-8
activation. Int J Mol Sci. 13:15523–15535. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim YS and Jin SH: Ginsenoside Rh2 induces
apoptosis via activation of caspase-1 and −3 and up-regulation of
Bax in human neuroblastoma. Arch Pharm Res. 27:834–839. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu GW, Liu YH, Jiang GS and Ren WD: The
reversal effect of Ginsenoside Rh2 on drug resistance in human
colorectal carcinoma cells and its mechanism. Hum Cell. 31:189–198.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou B, Xiao X, Xu L, Zhu L, Tan L, Tang
H, Zhang Y, Xie Q and Yao S: A dynamic study on reversal of
multidrug resistance by ginsenoside Rh2 in
adriamycin-resistant human breast cancer MCF-7 cells. Talanta.
88:345–351. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang J, Zhou F, Wu X, Gu Y, Ai H, Zheng
Y, Li Y, Zhang X, Hao G, Sun J, et al: 20(S)-ginsenoside Rh2
noncompetitively inhibits P-glycoprotein in vitro and in vivo: A
case for herb-drug interactions. Drug Metab Dispos. 38:2179–2187.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kwak JO, Lee SH, Lee GS, Kim MS, Ahn YG,
Lee JH, Kim SW, Kim KH and Lee MG: Selective inhibition of MDR1
(ABCB1) by HM30181 increases oral bioavailability and therapeutic
efficacy of paclitaxel. Eur J Pharmacol. 627:92–98. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Johnstone RW, Ruefli AA and Lowe SW:
Apoptosis: A link between cancer genetics and chemotherapy. Cell.
108:153–164. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Adams JM and Cory S: The Bcl-2 protein
family: Arbiters of cell survival. Science. 281:1322–1326. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu X, Sun Y, Yue L, Li S, Qi X, Zhao H,
Yang Y, Zhang C and Yu H: JNK pathway and relative transcriptional
factor were involved in ginsenoside Rh2-mediated G1 growth arrest
and apoptosis in human lung adenocarcinoma A549 cells. Genet Mol
Res. 15:2016. View Article : Google Scholar
|
|
26
|
Chen F, Zheng SL, Hu JN, Sun Y, He YM,
Peng H, Zhang B, McClements DJ and Deng ZY: Octyl ester of
ginsenoside Rh2 induces apoptosis and G1 cell cycle arrest in human
HepG2 cells by activating the extrinsic apoptotic pathway and
modulating the Akt/p38 MAPK signaling pathway. J Agric Food Chem.
64:7520–7529. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li KF, Kang CM, Yin XF, Li HX, Chen ZY, Li
Y, Zhang Q and Qiu YR: Ginsenoside Rh2 inhibits human A172 glioma
cell proliferation and induces cell cycle arrest status via
modulating Akt signaling pathway. Mol Med Rep. 17:3062–3068.
2018.PubMed/NCBI
|
